News
These 2 Aerospace Stocks Could Beat Earnings: Why They Should Be on Your Radar
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
How to Find Strong Computer and Technology Stocks Slated for Positive Earnings Surprises
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Why Investors Need to Take Advantage of These 2 Utilities Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Want Better Returns? Don't Ignore These 2 Retail and Wholesale Stocks Set to Beat Earnings
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Is the Options Market Predicting a Spike in Intercontinental Exchange Stock?
Investors in Intercontinental Exchange, Inc. ICE need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2025 $80 Call had some of the
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
Quest Diagnostics DGX is set to release its third-quarter 2025 results on Oct. 21, before the market opens.
The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.62 in the
Are Options Traders Betting on a Big Move in Goosehead Insurance Stock?
Investors in Goosehead Insurance, Inc. GSHD need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $55 Call had some of the highest
Goldman Sachs (GS) Q3 Earnings and Revenues Beat Estimates
Goldman Sachs (GS) came out with quarterly earnings of $12.25 per share, beating the Zacks Consensus Estimate of $11.11 per share. This compares to earnings of $8.4 per share a year ago. These
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
Hologic HOLX continues to experience strong momentum across its GYN Surgical portfolio, underscoring the increasing global focus on women’s health. The company’s investments in commercial and market
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
Although Intuitive Surgical ISRG delivered better-than-expected performance during second-quarter 2025, its shares have continued to decline. ISRG stock has moved down 14.9% in the past three
Rising AI Chip Demand to Boost Taiwan Semiconductor's Q3 Revenues
Taiwan Semiconductor Manufacturing Company Ltd. TSM is scheduled to release its third-quarter 2025 earnings on Oct. 16. The world’s top contract chipmaker looks well-positioned for another strong
Here's How Much a $1000 Investment in B2Gold Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Here's How Much a $1000 Investment in Emcor Group Made 10 Years Ago Would Be Worth Today
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
Micron Soars 171% in Six Months: Is MU Stock Still Worth Buying?
Micron Technology, Inc. MU has delivered a robust 171.4% gain over the past six months. This performance easily beats the broader Zacks Computer and Technology sector, which rose 39.4% in the same
Sono-Tek Corporation (SOTK) Q2 Earnings Beat Estimates
Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago
FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months
Denali Therapeutics Inc. DNLI announced that the FDA has extended its review timeline of the Biologics License Application (“BLA”) for pipeline candidate, tividenofusp alfa.
The BLA is seeking
Fastenal Stock Pulls Back in October—Is It Time to Buy FAST?
Fastenal Company (NASDAQ: FAST) stock is pulling back in October, and the Q3 results aren’t helping with support. However, the problem isn’t with growth, profitability, or capital returns so
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
The
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The easiest, most
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest way to judge a
Rare Earth ETF (REMX) Hits New 52-Week High
For investors seeking momentum, VanEck Rare Earth/Strategic Metals REMX is probably on the radar. The fund just hit a 52-week high and has soared 136% from its 52-week low of $32.36 per share.
Are
Oil Demand Resilience Shines in OPEC's Latest Market View
OPEC’s latest Monthly Oil Market Report offered a steady and confident tone, keeping its global demand growth forecasts unchanged for both 2025 and 2026. The cartel continues to expect demand to
3 Crypto-Centric Stocks to Buy on the Dip Before Bitcoin Resumes Rally
The cryptocurrency market suffered a bloodbath on Friday, with nearly $500 billion getting wiped out as panic gripped Wall Street after President Donald Trump threatened 100% tariffs on China
3 Reasons OKLO's All-Time High Close May Prove Short-Lived
Sam Altman-backed Oklo Inc. OKLO has been one of 2025’s most remarkable stock stories. The nuclear microreactor developer’s share price has soared from about $20 in April to over $170 — a stunning
Buy 5 Consumer Discretionary Stocks With Solid Upside Potential for Q4
The consumer discretionary sector witnessed moderate growth in the first three quarters of 2025, despite a strong rally in U.S. stock markets. The situation is likely to improve in the fourth


